These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 12196900)

  • 1. The role of chemotherapy and radiation in organ-preservation strategies for muscle-invasive bladder cancer.
    Bradley BA; Wajsman Z
    World J Urol; 2002 Aug; 20(3):167-74. PubMed ID: 12196900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical bladder preserving strategies in the treatment of muscle-invasive bladder cancer.
    Kuczyk M; Machtens S; Bokemeyer C; Kollmannsberger C; Hartmann J; Kondoh M; Merseburger A; Jonas U
    World J Urol; 2002 Aug; 20(3):183-9. PubMed ID: 12196902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodality bladder preservation therapy for muscle-invasive bladder tumors.
    Fernando SA; Sandler HM
    Semin Oncol; 2007 Apr; 34(2):129-34. PubMed ID: 17382796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of bladder cancer trials in the Radiation Therapy Oncology Group.
    Shipley WU; Kaufman DS; Tester WJ; Pilepich MV; Sandler HM;
    Cancer; 2003 Apr; 97(8 Suppl):2115-9. PubMed ID: 12673704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organ-sparing strategies in the management of invasive bladder cancer.
    Yafi FA; Cury FL; Kassouf W
    Expert Rev Anticancer Ther; 2009 Dec; 9(12):1765-75. PubMed ID: 19954288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of radiation therapy and combined-modality treatment for bladder cancer.
    Rödel C
    Strahlenther Onkol; 2004 Nov; 180(11):701-9. PubMed ID: 15549188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of radiation-based conservation therapy for invasive bladder cancer.
    Chung PW; Bristow RG; Milosevic MF; Yi QL; Jewett MA; Warde PR; Catton CN; McLean M; Moore M; Tannock IF; Gospodarowicz MK
    Urol Oncol; 2007; 25(4):303-9. PubMed ID: 17628296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bladder preservation: optimizing radiotherapy and integrated treatment strategies.
    Mak RH; Zietman AL; Heney NM; Kaufman DS; Shipley WU
    BJU Int; 2008 Nov; 102(9 Pt B):1345-53. PubMed ID: 19035903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opportunities with combined modality therapy for selective organ preservation in muscle-invasive bladder cancer.
    Colvett KT; Althausen AF; Bassil B; Heney NM; McGovern FV; Young HH; Kaufman DS; Zietman AL; Shipley WU
    J Surg Oncol; 1996 Nov; 63(3):201-8. PubMed ID: 8944067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of bladder-conserving strategies in muscle-invasive bladder carcinoma compared with radical surgery.
    Merseburger AS; Kuczyk MA
    Curr Opin Urol; 2007 Sep; 17(5):358-62. PubMed ID: 17762631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Perioperative strategies in patients with muscle invasive bladder cancer].
    Pouessel D; Thariat J; Lagrange JL; Mottet N; Culine S
    Bull Cancer; 2010; 97 Suppl Cancer de la vessie():5-9. PubMed ID: 20534384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
    Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
    J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organ preservation strategies in bladder cancer.
    Hussain SA; James ND
    Expert Rev Anticancer Ther; 2002 Dec; 2(6):641-51. PubMed ID: 12503210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy for muscle-invasive bladder cancer treated with definitive radiotherapy: persisting uncertainties.
    Choueiri TK; Raghavan D
    Nat Clin Pract Oncol; 2008 Aug; 5(8):444-54. PubMed ID: 18577983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy: long term results.
    Danesi DT; Arcangeli G; Cruciani E; Altavista P; Mecozzi A; Saracino B; Orefici F
    Cancer; 2004 Dec; 101(11):2540-8. PubMed ID: 15481058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organ preservation in muscle-invasive bladder cancer.
    Fernando SA; Sandler HM
    Oncology (Williston Park); 2005 Mar; 19(3):334-9; discussion 339-40, 345, 349, 350-3. PubMed ID: 15828550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemoradiotherapy for muscle-invasive cancer: methods, surveillance and results. An update from the cancer committee of the French National Association of Urology].
    Quintens H; Roupret M; Larré S; Neuzillet Y; Pignot G; Compérat E; Wallerand H; Houédé N; Roy C; Soulié M; Pfister C;
    Prog Urol; 2012 Jan; 22(1):13-6. PubMed ID: 22196000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary?
    Wo JY; Shipley WU; Dahl DM; Coen JJ; Heney NM; Kaufman DS; Zietman AL
    BJU Int; 2009 Jul; 104(2):179-83. PubMed ID: 19154448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bladder-sparing therapy for muscle-infiltrating bladder cancer.
    Pansadoro V; Emiliozzi P
    Nat Clin Pract Urol; 2008 Jul; 5(7):368-75. PubMed ID: 18560383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy.
    Solsona E; Climent MA; Iborra I; Collado A; Rubio J; Ricós JV; Casanova J; Calatrava A; Monrós JL
    Eur Urol; 2009 Apr; 55(4):911-9. PubMed ID: 18722046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.